Decreased plasma levels of soluble receptor for advanced glycation end products in mild cognitive impairment

被引:0
|
作者
R. Ghidoni
L. Benussi
M. Glionna
M. Franzoni
D. Geroldi
E. Emanuele
G. Binetti
机构
[1] IRCCS “Centro S. Giovanni di Dio-FBF”,NeuroBioGen Lab
[2] AFaR,Memory Clinic
[3] University of Pavia,Interdepartmental Center for Research in Molecular Medicine (CIRMC)
来源
关键词
Biological marker; Plasma; Mild cognitive impairment; sRAGE; AD; Cognitive decline;
D O I
暂无
中图分类号
学科分类号
摘要
Growing evidence advanced the idea that the soluble form of the receptor for advanced glycation end-products (sRAGE) might serve as a risk marker for several disorders including Alzheimer disease. We found a reduced level of circulating sRAGE in patients with mild cognitive impairment (MCI). The reduction of sRAGE in MCI, as well as the anticipation of the disease in patients with the lowest sRAGE levels (≤225 pg/ml), suggest a role of the RAGE axis in the pathogenesis of the disease.
引用
收藏
页码:1047 / 1050
页数:3
相关论文
共 50 条
  • [1] Decreased plasma levels of soluble receptor for advanced glycation end products in mild cognitive impairment
    Ghidoni, R.
    Benussi, L.
    Glionna, M.
    Franzoni, M.
    Geroldi, D.
    Emanuele, E.
    Binetti, G.
    JOURNAL OF NEURAL TRANSMISSION, 2008, 115 (07) : 1047 - 1050
  • [2] Serum levels of advanced glycation end products and their receptor in the elderly diabetic patients with mild cognitive impairment
    Gorska-Ciebiada, M.
    Saryusz-Wolska, M.
    Borkowska, A.
    Ciebiada, M.
    Loba, J.
    DIABETOLOGIA, 2015, 58 : S114 - S114
  • [3] Decreased plasma levels of soluble receptor for advanced glycation end-products in patients with essential hypertension
    Geroldi, D
    Falcone, C
    Emanuele, E
    D'Angelo, A
    Calcagnino, M
    Buzzi, MP
    Scioli, GA
    Fogari, R
    JOURNAL OF HYPERTENSION, 2005, 23 (09) : 1725 - 1729
  • [4] Receptor for Advanced Glycation End Products: Dementia and Cognitive Impairment
    Singh, Aditya
    Ansari, Vaseem Ahamad
    Mahmood, Tarique
    Ahsan, Farogh
    Wasim, Rufaida
    Shariq, Mohammad
    Parveen, Saba
    Maheshwari, Shubhrat
    DRUG RESEARCH, 2023, 73 (05) : 247 - 250
  • [5] Plasma levels of soluble receptor for advanced glycation end products in Alzheimer's disease
    Xu, Xiao-Yan
    Deng, Chang-Qing
    Wang, Jian
    Deng, Xiao-Juan
    Xiao, Qian
    Li, Yuan
    He, Qi
    Fan, Wen-Hui
    Quan, Feng-Ying
    Zhu, Yao-Ping
    Cheng, Ping
    Chen, Guo-Jun
    INTERNATIONAL JOURNAL OF NEUROSCIENCE, 2017, 127 (05) : 454 - 458
  • [6] Plasma aminothiol compounds, but not serum tumor necrosis factor receptor II and soluble receptor for advanced glycation end products, are related to the cognitive impairment in Alzheimer's disease and mild cognitive impairment patients
    Hernanz, Angel
    De la Fuente, Monica
    Navarro, Mercedes
    Frank, Ana
    NEUROIMMUNOMODULATION, 2007, 14 (3-4) : 163 - 167
  • [7] Decreased levels of soluble receptor for advanced glycation end products in patients with primary Sjogren's syndrome
    Stewart, Carol
    Cha, Seunghee
    Caudle, Robert M.
    Berg, Kathleen
    Katz, Joseph
    RHEUMATOLOGY INTERNATIONAL, 2008, 28 (08) : 771 - 776
  • [8] Decreased levels of soluble receptor for advanced glycation end-products in aortic valve calcification patients
    Zheng, H.
    Li, Y.
    Xie, N.
    Huang, J. L.
    Xu, H. F.
    Luo, M.
    GENETICS AND MOLECULAR RESEARCH, 2015, 14 (02): : 3775 - 3783
  • [9] Soluble receptor for advanced glycation end products in patients with decreased renal function
    Kalousová, M
    Hodková, M
    Kazderová, M
    Fialová, J
    Tesar, V
    Dusilová-Sulková, S
    Zima, T
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2006, 47 (03) : 406 - 411
  • [10] The Plasma Level of Soluble Receptor for Advanced Glycation End Products is Decreased in Patients with Systemic Lupus Erythematosus
    Ma, C. -Y.
    Ma, J. -L.
    Jiao, Y. -L.
    Li, J. -F.
    Wang, L. -C.
    Yang, Q. -R.
    You, L.
    Cui, B.
    Chen, Z. -J.
    Zhao, Y. -R.
    SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2012, 75 (06) : 614 - 622